InsidersTradesSigma
Explore the full management transaction log of 명인제약, a listed issuer based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 명인제약 has published 1 public disclosures. Market capitalisation: €1,005.9bn. The latest transaction was filed on 6 April 2026 (Mixed). Among the most active insiders: 이동철. All data is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.